{"public_id":"co_507acf8fbdcd355dc0b761ca19d2f307","status":"active","merged_into_public_id":null,"resolved_public_id":"co_507acf8fbdcd355dc0b761ca19d2f307","name":"NASH-HCC models","description":"Mouse models of nonalcoholic steatohepatitis that progress to hepatocellular carcinoma, used to evaluate the effects of FGF21 and anti-IL-17A antibody.","aliases":[],"types":["animal model"],"contributors":[{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["extraction"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":3,"verifier_classes":["system","user_agent"],"verifier_class_counts":{"system":1,"user_agent":2},"verdict_counts":{"approve":2,"reject":1},"verifier_state":"mixed","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":221362281,"title":"Lack of FGF21 promotes NASH-HCC transition via hepatocyte-TLR4-IL-17A signaling","citation_count":67,"url":"https://sah.borca.ai/papers/221362281"}],"claims":[{"public_id":"cl_fefb9e6f8735febbf90c4f3ea6e2cccd","text":"Treatment with anti-IL-17A antibody significantly reduces HCC nodule number and tumor size in NASH-HCC models.","corpus_id":221362281,"url":"https://sah.borca.ai/claims/cl_fefb9e6f8735febbf90c4f3ea6e2cccd"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_507acf8fbdcd355dc0b761ca19d2f307","url":"https://sah.borca.ai/concepts/co_507acf8fbdcd355dc0b761ca19d2f307"}